CAMMA-1
Phase 1B Clinical Trial Studying the Safety, Activity, and Effectiveness of Cevostamab in Treating People with Relapsed or Refractory Multiple Myeloma
Arms / Cohorts
Cohort C1E:Cevostamab + Daratumumab + Dexamethasone
Not yet accepting
Cohort C2E:Cevostamab + Daratumumab + Dexamethasone
Not yet accepting
Cohort B1S:Cevostamab + Pomalidomide + Dexamethasone
Not currently accepting
Cohort B1E:Cevostamab + Pomalidomide + Dexamethasone
Not currently accepting
Cohort B2E:Cevostamab + Pomalidomide + Dexamethasone
Not currently accepting
Cohort C1S:Cevostamab + Daratumumab + Dexamethasone
Not currently accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.